NCT07622186 2026-06-03A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Phase 2 Not yet recruiting150 enrolled